Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Proteolytic cleavage of PR-B: A novel mechanism for functional progesterone withdrawal in human parturition

Award Number: R21HD122975
ORGANIZATION: NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2026
PERIOD OF PERFORMANCE END DATE: 08/31/2028

Group Awards By:

View Award Description

Proteolytic cleavage of PR-B: A novel mechanism for functional progesterone withdrawal in human parturition - PROJECT SUMMARY/ABSTRACT Spontaneous preterm (<37 weeks of gestation) labor (PTL) that leads to preterm birth (PTB) affects 10- 15% of pregnancies and causes 80-90% of neonatal mortality and morbidity. Currently, there are no effective therapies to prevent PTL/PTB, and the mechanism by which labor is initiated is unknown. Our research focuses on the steroid hormone progesterone and how its action in uterine cells is regulated to maintain pregnancy and induce labor and parturition. For most of pregnancy, P4, acting via the nuclear P4 receptors (PRs) affects expression of specific genes in myometrial cells, the net effect of which is to promote uterine relaxation and quiescence (i.e., pro-gestation). A common trait among viviparous species is that loss/disruption of P4/PR signaling induces labor, leading to parturition. The human PR exists as at least 2 isoforms: PR-A and PR-B, that share amino acid sequence except that PR-B has an extra 164 N-terminal (NT) amino acids. We found that in myometrial cells, pro-pregnancy actions of P4 are mediated by PR-B transcriptional activity, whereas PR-A inhibits the activity of PR-B and directly promotes expression of pro- labor genes. This led to the hypothesis that labor ensues when P4 signaling in myometrial transitions from PR-B to PR-A. The proposed studies explore a novel mechanism for this transition: proteolytic cleavage of the PR-B NT region leading to depletion of PR-B and accumulation of a PR-A-like cleavage product. The central hypothesis is that PR-B NT cleavage decreases PR-B transcriptional activity, due to loss of the NT region of PR-B, and production of a PR-A analogue cleavage product (PR-BΔNT) that promotes expression of pro-labor genes. This hypothesis will be tested by achieving 2 Specific Aims: 1) identify the amino acid locus for PR-B NT cleavage in myometrial cells; and 2) determine the effect of PR-B NT cleavage and PR- BΔNT on myometrial cell P4 responsiveness. PR-B NT cleavage is a hitherto unrecognized mechanism that may cause the loss of P4/PR-B signaling in myometrial cells that initiates labor. The research has groundbreaking potential for understanding the pathophysiology of PTL/PTB and may lead to novel therapeutic strategies (e.g., inhibition of the PR-B NT cleavage protease) to prevent PTL/PTB. PR-B NT cleavage may also have relevance for other P4/PR-related pathologies such as endometriosis, leiomyoma, and breast cancer.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $431,750 )
2026	2026	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Child Health and Human Development Extramural Research	000	1	8/21/2026	NEW	$431,750
														Subtotal = $431,750

Grand Total All Awards = $431,750

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Proteolytic cleavage of PR-B: A novel mechanism for functional progesterone withdrawal in human parturition

Award Number: R21HD122975

ORGANIZATION: NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2026

PERIOD OF PERFORMANCE END DATE: 08/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer